BioPharma Dive – AI / Data
Karyopharm myeloma drug yields mixed data in myelofibrosis trial
Xpovio combined with Incyte’s Jakafi helped on one key measure but missed on other goal in a disorder that, by one analyst’s estimates, could triple the company’s revenue.